{{Rsnum
|rsid=1437898
|Gene=NCKAP5
|Chromosome=2
|position=132989057
|Orientation=minus
|GMAF=0.4334
|Assembly=GRCh38
|GenomeBuild=38.1
|dbSNPBuild=141
|geno1=(G;G)
|geno2=(G;T)
|geno3=(T;T)
|Gene_s=NCKAP5
}}{{ population diversity
| geno1=(G;G)
| geno2=(G;T)
| geno3=(T;T)
| CEU | 38.9 | 46.9 | 14.2
| HCB | 38.0 | 52.6 | 9.5
| JPT | 49.6 | 40.7 | 9.7
| YRI | 18.4 | 44.9 | 36.7
| ASW | 17.5 | 43.9 | 38.6
| CHB | 38.0 | 52.6 | 9.5
| CHD | 37.6 | 46.8 | 15.6
| GIH | 36.6 | 47.5 | 15.8
| LWK | 13.6 | 47.3 | 39.1
| MEX | 31.0 | 46.6 | 22.4
| MKK | 36.5 | 51.9 | 11.5
| TSI | 46.1 | 41.2 | 12.7
| HapMapRevision=28
}}{{PMID Auto GWAS
|PMID=19010793
|Trait=Multiple sclerosis (age of onset)
|Title=Genome-wide association analysis of susceptibility and clinical phenotype in multiple sclerosis
|RiskAllele=
|Pval=0.000008
|OR=NR
|ORtxt=NR
}}

{{PharmGKB
|RSID=rs1437898
|Name_s=
|Gene_s=NCKAP5
|Feature=
|Evidence=PubMed ID:19010793; Web Resource:http://www.genome.gov/gwastudies/
|Annotation=GWAS results: Genome-wide association analysis of susceptibility and clinical phenotype in multiple sclerosis. (Initial Sample Size: 978 cases, 883 controls; Replication Sample Size: NR); (Region: 2q21.2; Reported Gene(s): FLJ34870; Risk Allele: rs1437898-?); (p-value= 0.000008).This variant is associated with Multiple sclerosis (age of onset).
|Drugs=
|Drug Classes=
|Diseases=Multiple Sclerosis
|Curation Level=Non-Curated
|PharmGKB Accession ID=PA164740725
}}

{{GET Evidence
|impact=pathogenic
|qualified_impact=Insufficiently evaluated pathogenic
|inheritance=unknown
|quality_scores=Array
|dbsnp_id=rs1437898
|overall_frequency_n=70
|overall_frequency_d=128
|overall_frequency=0.546875
|n_genomes=40
|n_genomes_annotated=0
|n_haplomes=56
|n_articles=0
|n_articles_annotated=0
|in_gwas=Y
|in_pharmgkb=Y
|autoscore=2
|webscore=N
}}

{{on chip | 23andMe v1}}
{{on chip | 23andMe v2}}
{{on chip | 23andMe v3}}
{{on chip | 23andMe v4}}
{{on chip | Illumina Human 1M}}